دورية أكاديمية
أعرض في EDS

Prevalence of Hepatitis D in People Living with HIV: A National Cross-Sectional Pilot Study.

التفاصيل البيبلوغرافية
العنوان: Prevalence of Hepatitis D in People Living with HIV: A National Cross-Sectional Pilot Study.
المؤلفون: Schinas G; School of Medicine, University of Patras, 26504 Patras, Greece., Antonopoulou N; School of Medicine, University of Patras, 26504 Patras, Greece., Vamvakopoulou S; Department of Microbiology, University General Hospital of Patras, 26504 Patras, Greece., Tsachouridou O; Departments of Internal Medicine and Infectious Diseases, University General Hospital of Thessaloniki 'AHEPA', 54636 Thessaloniki, Greece., Protopapas K; 4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University General Hospital, 12462 Athens, Greece., Petrakis V; Departments of Internal Medicine and Infectious Diseases, Democritus University of Thrace, 68100 Alexandroupolis, Greece., Petrakis EC; Departments of Internal Medicine and Infectious Diseases, University General Hospital of Heraklion, 71500 Heraklion, Greece., Papageorgiou D; School of Medicine, University of Patras, 26504 Patras, Greece., Metallidis S; Departments of Internal Medicine and Infectious Diseases, University General Hospital of Thessaloniki 'AHEPA', 54636 Thessaloniki, Greece., Papadopoulos A; 4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University General Hospital, 12462 Athens, Greece., Barbounakis E; Departments of Internal Medicine and Infectious Diseases, University General Hospital of Heraklion, 71500 Heraklion, Greece., Kofteridis D; Departments of Internal Medicine and Infectious Diseases, University General Hospital of Heraklion, 71500 Heraklion, Greece., Panagopoulos P; Departments of Internal Medicine and Infectious Diseases, Democritus University of Thrace, 68100 Alexandroupolis, Greece., Lekkou A; Departments of Internal Medicine and Infectious Diseases, University General Hospital of Patras, 26504 Patras, Greece., Paliogianni F; Department of Microbiology, University General Hospital of Patras, 26504 Patras, Greece., Akinosoglou K; School of Medicine, University of Patras, 26504 Patras, Greece.; Departments of Internal Medicine and Infectious Diseases, University General Hospital of Patras, 26504 Patras, Greece.
المصدر: Viruses [Viruses] 2024 Jun 28; Vol. 16 (7). Date of Electronic Publication: 2024 Jun 28.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI
مواضيع طبية MeSH: HIV Infections*/epidemiology , HIV Infections*/virology , Hepatitis D*/epidemiology , Hepatitis Delta Virus*/immunology , Hepatitis Delta Virus*/genetics , Coinfection*/epidemiology , Coinfection*/virology , Hepatitis Antibodies*/blood, Humans ; Cross-Sectional Studies ; Male ; Female ; Middle Aged ; Pilot Projects ; Greece/epidemiology ; Adult ; Prevalence ; Aged ; RNA, Viral/blood ; Seroepidemiologic Studies
مستخلص: This study assesses the prevalence of hepatitis D virus (HDV) in people living with HIV (PLWHIV) in Greece. Given the compounding effects of HDV and hepatitis B (HBV) on liver disease progression, as well as the emergence of new therapeutic options such as bulevirtide, understanding regional disparities and the epidemiological impact of such co-infections is vital. A cross-sectional analysis was conducted utilizing 696 serum samples from PLWHIV attending five major university hospitals. The methodology included HDV antibody detection by ELISA and HDV RNA confirmation. Of the 30 HBsAg-positive samples analyzed, the study population was primarily male (93%), with a median age of 54 years. Participants had been on antiretroviral therapy for a median of 10 years, and the median CD4 count was 738 (539-1006) copies/mL. Additional serological findings revealed a 7% prevalence of hepatitis C virus (HCV) IgG antibodies and a 55% prevalence of hepatitis A virus (HAV) IgG antibodies. Seroreactivity for syphilis (RPR/VDRL/TPHA positive) was identified in 33% of the participants. The results indicated a low HDV prevalence, with only one individual (3%) testing positive for anti-HDV IgG antibodies and none for HDV RNA. This indicates a lower prevalence of HDV among PLWHIV with chronic HBV in Greece compared to global data.
References: Drugs. 2020 Oct;80(15):1601-1605. (PMID: 32926353)
J Viral Hepat. 2023 Nov;30(11):879-888. (PMID: 37488783)
JHEP Rep. 2022 Jul 21;4(10):100547. (PMID: 36052219)
Nat Rev Gastroenterol Hepatol. 2010 Jan;7(1):31-40. (PMID: 20051970)
Liver Int. 2023 Apr;43(4):819-828. (PMID: 36625770)
Liver Int. 2023 Sep;43(9):1879-1889. (PMID: 37288712)
J Viral Hepat. 2021 Jul;28(7):1057-1067. (PMID: 33877742)
HIV AIDS (Auckl). 2021 May 05;13:485-490. (PMID: 33981165)
Front Med (Lausanne). 2023 Jan 27;10:1086012. (PMID: 36778739)
JAMA. 2023 Dec 26;330(24):2376-2387. (PMID: 37943548)
Lancet Infect Dis. 2023 Jan;23(1):117-129. (PMID: 36113537)
JHEP Rep. 2024 Mar 26;6(8):101057. (PMID: 39045338)
PLoS One. 2021 Apr 27;16(4):e0250347. (PMID: 33905426)
HIV Med. 2023 Oct;24(10):1075-1082. (PMID: 37287427)
Pathogens. 2024 Jun 24;13(7):. (PMID: 39057763)
Front Microbiol. 2021 Jun 21;12:652962. (PMID: 34234753)
Gut. 2019 Mar;68(3):512-521. (PMID: 30228220)
Viruses. 2022 Aug 10;14(8):. (PMID: 36016371)
JMIR Public Health Surveill. 2022 Nov 29;8(11):e37016. (PMID: 36445732)
N Engl J Med. 2023 Jul 6;389(1):22-32. (PMID: 37345876)
Pathog Glob Health. 2023 Mar;117(2):181-189. (PMID: 35249472)
J Hepatol. 2020 Sep;73(3):523-532. (PMID: 32335166)
J Hepatol. 2023 Aug;79(2):433-460. (PMID: 37364791)
Gastroenterol Rep (Oxf). 2019 Jun 23;7(4):231-245. (PMID: 32477569)
Clin Liver Dis (Hoboken). 2018 Aug 22;12(1):33-34. (PMID: 30988907)
J Infect Dis. 1990 Nov;162(5):1170-2. (PMID: 2121838)
Gut. 2000 Mar;46(3):420-6. (PMID: 10673308)
Liver Int. 2023 Aug;43 Suppl 1:108-115. (PMID: 35748639)
Gastroenterol Rep (Oxf). 2019 Oct 19;7(6):396-402. (PMID: 32494363)
J Hepatol. 2013 Nov;59(5):949-56. (PMID: 23850875)
Clin Infect Dis. 2007 Apr 1;44(7):988-95. (PMID: 17342655)
معلومات مُعتمدة: Gilead Sciences
فهرسة مساهمة: Keywords: Greece; HIV infections; coinfection; epidemiological monitoring; hepatitis B; hepatitis D
المشرفين على المادة: 0 (Hepatitis Antibodies)
0 (RNA, Viral)
تواريخ الأحداث: Date Created: 20240727 Date Completed: 20240727 Latest Revision: 20240729
رمز التحديث: 20240729
مُعرف محوري في PubMed: PMC11281684
DOI: 10.3390/v16071044
PMID: 39066206
قاعدة البيانات: MEDLINE
الوصف
تدمد:1999-4915
DOI:10.3390/v16071044